Thank you, Madam Chair.
I want to thank all the witnesses for their presentations.
I have a question for Ms. Whattam.
In March, the committee heard from you at a meeting on the reform of the World Trade Organization. You pointed out that the globalization regime, business investments and supply chains have led to the outsourcing of certain industries. In particular, pharmaceutical production capacity is now centralized in developed countries, meaning wealthy countries. In many respects, even in wealthy countries, we can see this approach.
As we know, Canada and Quebec once had real pharmaceutical capacity. However, this capacity has declined as a result of unscrupulous and unregulated privatization or public-private partnerships.
Have we missed a great opportunity, in Canada and in Quebec, to have our own industry?